In conclusion, our data suggest that plasma Aβ42/40 and p‐τ181 are specific plasma biomarkers for the development of AD, and plasma GFAP and NfL are potential biomarkers for all‐cause dementia in the general older population. This evidence concerns the gene GFAP and Alzheimer disease.